why choose us

First received: April 21, 2025

Clinical Trial: Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D [Launchpad Lyumjev]

Brief Summary: A randomized controlled trial of Control-IQ, assessing glycemic control (time-in-range 70-180 mg/dL) for Lyumjev insulin (in which the insulin settings have been determined using an experimental conversion factor) as compared to Humalog or Novolog (using optimized settings)

Read more